| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |